A philosophy of science approach to the amyloid hypothesis of Alzheimer's disease

T Daly - European Journal of Neuroscience, 2024 - Wiley Online Library
Disputes about the scientific validity of the amyloid‐β hypothesis of Alzheimer's disease
have been held since the early 1990s, with little constructive progress made between …

Dapagliflozin ameliorates cognitive impairment in Aluminum-chloride-induced Alzheimer's disease via modulation of AMPK/mTOR, oxidative stress and glucose …

WA Samman, SM Selim, HM El Fayoumi, NM El-Sayed… - Pharmaceuticals, 2023 - mdpi.com
Alzheimer's disease (AD) is a progressive neurological illness characterized by memory loss
and cognitive deterioration. Dapagliflozin was suggested to attenuate the memory …

JAD: a forum for philosophy in science

T Daly - Journal of Alzheimer's Disease, 2023 - content.iospress.com
Abstract The Journal of Alzheimer's Disease (JAD) is already an established forum for
cutting-edge science as well as ethical reflection. But I argue that beyond science and …

[PDF][PDF] Navigating academic excellence: Understanding how university vision impacts staff effectiveness

ME Ogbari - Human Resources Management and …, 2024 - pdfs.semanticscholar.org
Vision statements are seen as important factors that come before the development of
strategies. They excel in encapsulating the strategic direction of a company, clearly defining …

The letter as a forum to promote diversity in dementia research

T Daly - Dementia & Neuropsychologia, 2023 - SciELO Brasil
Three major obstacles for dementia researchers in Latin America have been identified:
funding constraints, language barriers, and article processing charges (APCs) 1, 2. It is vital …

[PDF][PDF] Interventional Philosophy in Medicine: Formulating Hypotheses

T Daly - Philosophy of Medicine, 2024 - philsci-archive.pitt.edu
Advocates of philosophy in science and biomedicine argue that philosophers can embed
their ideas into scientific research in order to help solve scientific problems (Pradeu et al …

Reply: Lecanemab: turning point, or status quo? An ethics perspective

J Hardy, C Mummery - Brain, 2023 - academic.oup.com
We are pleased to respond to Dr Daly's critique of our commentary 1 on anti-amyloid trials. 2
We were surprised that he deemed such trials 'unethical': this is both legally suspect, as all …